Johnson & Johnson Allowed To Move Ahead With Bankruptcy Strategy On Talc Lawsuits: WSJ

Loading...
Loading...

In a federal bankruptcy court in Trenton, New Jersey, Judge Michael Kaplan ruled in favor of Johnson & Johnson's JNJ controversial bankruptcy filing meant to settle 38,000 claims alleging its talc-based products caused cancer.

  • According to the Wall Street Journal report, the ruling will allow a J&J subsidiary, LTL Management, to proceed with its chapter 11 filing and freezes all outstanding talc litigation while J&J pursues a settlement.
  • Kaplan wrote that J&J's bankruptcy plan was not done in bad faith but rather to resolve mass litigation.
  • Also see: Johnson & Johnson To Defend Baby-Powder Lawsuits In Court: Report.
  • Plaintiffs' attorneys had argued that the bankruptcy plan was part of a "Texas Two-Step" legal maneuver to minimize potential payouts related to the allegations.
  • Last week, a lawyer for J&J's bankrupt subsidiary, LTL Management, said the parent company was close to a talc settlement last year that would have cost between $4 billion and $5 billion, which was more than double the figure J&J offered to resolve the liability through the bankruptcy procedure. 
  • Price Action: JNJ shares are down 1.25% at $163.93 during the market session on the last check Monday.
Market News and Data brought to you by Benzinga APIs
Posted In: BiotechNewsHealth CareLegalGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...